Visualitza per autor "Blay, Jean-Yves"
Ara mostrant els elements 1-6 d 6
-
An Approach to Solving the Complex Clinicogenomic Data Landscape in Precision Oncology: Learnings From the Design of WAYFIND-R, a Global Precision Oncology Registry
Perret, Camille; Hackshaw, Allan; Nabholz, Christoph; Geissler, Jan; Le Tourneau, Christophe; Blay, Jean-Yves; Dienstmann, Rodrigo (American Society of Clinical Oncology, 2022-08-08) -
Imatinib in combination with phosphoinositol kinase inhibitor buparlisib in patients with gastrointestinal stromal tumour who failed prior therapy with imatinib and sunitinib: a Phase 1b, multicentre study
Jones, Robin L.; Valverde Morales, Claudia Maria; Benson, Charlotte; Blay, Jean-Yves; Gelderblom, Hans; George, Suzanne (Springer Nature, 2020-04-14) -
Novel trial designs for patients with gastrointestinal stromal tumor
Rothschild, Sara; Heinrich, Michael; Serrano, Cesar; Villacampa Javierre, Guillermo; George, Suzanne; Blay, Jean-Yves; Navarro Garces, Victor (Elsevier, 2024-01) -
Patient-reported outcomes and tolerability in patients receiving ripretinib versus sunitinib after treatment with imatinib in INTRIGUE, a phase 3, open-label study
Gelderblom, Hans; Jones, Robin; Blay, Jean-Yves; George, Suzanne; von Mehren, Margaret ; Zalcberg, John; Serrano, Cesar (Elsevier, 2023-07-20) -
Phase II multicohort study of atezolizumab monotherapy in multiple advanced solid cancers
Tabernero Caturla, Josep; André, Fabrice; Bustillos, A.; Fear, S.; Ganta, S.; Blay, Jean-Yves (Elsevier, 2022-04) -
SELNET clinical practice guidelines for bone sarcoma
Palmerini, Emanuela; Bollard, Julien; Aguiar Júnior, Samuel; Angel, Martín; B, Araya; Valverde Morales, Claudia Maria; Blay, Jean-Yves (Elsevier, 2022-06)